贝恩公司：2024年全球医疗健康行业私募股权报告（英文版）

Investors continue trying to unlock liquidity and raise capital for healthcare deals, in a challenging fund-raising environment. Biopharma deals represent the biggest share of healthcare buyouts, while new modalities and innovative therapies such as GLP-1s transform the investment landscape. As investors look to diversify their Asia-Pacific buyout activity, India is viewed as a place to deploy healthcare capital at scale. Private equity investors continue to pursue healthcare IT deals, with risi